新开源(300109.SZ)2020年净利预降55.21%-63.35%
格隆汇1月28日丨新开源(300109.SZ)披露2020年度业绩预告,公司预计2020年度实现归属于上市公司股东的净利润4500万元-5500万元,同比下降63.35%-55.21%。业绩变动原因系:
1、2020年度消费类特种化学品板块经营业务平稳有序发展,同比经营业绩基本持平;健康医疗服务板块BioVision公司受新冠肺炎疫情影响较小,营业收入同比增长约13%;境内健康医疗服务板块受疫情影响较大,业绩出现亏损。
2、公司根据《企业会计准则第8号—资产减值》、《会计监管风险提示第8号—商誉减值》的相关要求,公司对2015年以来并购的子公司进行了减值测试,预计长沙三济生物科技有限公司需计提商誉减值金额约4000万元,导致公司2020年度业绩下降较大。最终商誉减值计提的金额将由公司聘请的具备证券期货从业资格的评估机构及审计机构进行评估和审计后确定。
3、报告期非经常性损益对公司净利润的影响金额约为1600万元,主要系投资永泰生物所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.